Early Oral Switch for Uncomplicated Gram-negative Bacteraemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Oral Switch for Uncomplicated Gram-negative Bacteraemia — Stella

Recruiting

Back to Gram-negative Bacteraemia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Singapore

Tan Tock Seng Hospital, Singapore, Singapore

Key details

Phase

Post-approval study

Sponsor

Tan Tock Seng Hospital

Collaborators

National University Hospital, Singapore, Singapore General Hospital

Enrollment target

~720 participants

Started

June 2022

Primary completion

May 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov